You can now bet on measles. Preventing an outbreak used to be the obvious winning outcome. Finance has made the question more sophisticated.

Polymarket and Kalshi offer health-related contracts covering matters such as drug trials, vaccine policy and measles counts, the Guardian reports. They operate under federal commodities rules rather than ordinary state gambling regulation. The wager has put on a tie.

Kalshi says its clinical-trial markets could make scattered expert knowledge more visible. Health-policy experts warn that they could also reward leaks of confidential information. Nothing improves confidence in medical research like wondering who got the result before you and what price they got it at.

The Daily Heckler: five or six selected stories.
Political satire for your morning inbox.

That is a risk, not evidence that a particular trial was manipulated. It is nevertheless an odd feature to add to healthcare voluntarily.

Johns Hopkins professor Matthew Eisenberg also cautions that small contracts can be moved by a single trader. A few hundred dollars on vaccine policy is not public opinion. We have found a way to give one person’s wager the presentation of a national forecast.

On a Brooklyn fence, someone tore the betting text and logo off a Polymarket vaccine sign, leaving only the word Vaccines.

An advertisement became more useful after losing its business model.